Cargando…
Is there a benefit of ICD treatment in patients with persistent severely reduced systolic left ventricular function after TAVI?
BACKGROUND: In patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) and heart failure with severely reduced ejection fraction, prediction of postprocedural left ventricular ejection fraction (LVEF) improvement is challenging. Decision-making and timing...
Autores principales: | Nies, Richard J., Frerker, Christian, Adam, Matti, Kuhn, Elmar, Mauri, Victor, Nettersheim, Felix S., Braumann, Simon, Wahlers, Thorsten, Baldus, Stephan, Schmidt, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054877/ https://www.ncbi.nlm.nih.gov/pubmed/33758967 http://dx.doi.org/10.1007/s00392-021-01826-x |
Ejemplares similares
-
Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
por: Mauri, Victor, et al.
Publicado: (2020) -
Nitro-Oleic Acid (NO(2)-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis
por: Braumann, Simon, et al.
Publicado: (2021) -
Valve-in-Valve TAVR versus Redo Surgical Aortic Valve Replacement: Early Outcomes
por: Cizmic, Amila, et al.
Publicado: (2021) -
Protective Effects of Therapeutic Neutrophil Depletion and Myeloperoxidase Inhibition on Left Ventricular Function and Remodeling in Myocardial Infarction
por: Guthoff, Henning, et al.
Publicado: (2022) -
Contemporary treatment of mitral valve disease with transcatheter mitral valve implantation
por: Wienemann, Hendrik, et al.
Publicado: (2022)